BSE filing, NSE: FORTIS. Summary written from the filing by ALFA Finder's alert engine.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹819.80
- Market cap
- ₹61,891 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 59.1×Sector 54.5×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 23.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue INR 2,735 Cr (+17.3%), PAT INR 317 Cr (+4.0%, 11.6% margin); H1 revenue INR 5,280 Cr (+17.4%). Net debt/EBITDA 0.87x. Expansion via Suguna acquisition and SLJ Delhi agreement.
Fortis Healthcare Results Update
Fortis Healthcare released a press release on Q2 FY27 results, with consolidated revenue of INR 2,735 Cr up 17.3%. It also disclosed the Suguna Hospital acquisition and a 400+ bed Delhi hospital services agreement.
- hospital beds acquired
- 110.0 beds
Fortis Healthcare Q2 FY27 Results: Net Profit ₹320.5 Cr, Down 2.5% YoY
Fortis Healthcare approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026 at its board meeting on November 5, 2026. The filing encloses the results and a limited review report with an emphasis on a SFIO fraud investigation.
- Key figure
- Net profit ₹320.5 Cr · -2.5% YoY
Fortis Healthcare Management Change
Fortis Healthcare's Chief Growth & Innovation Officer, Dr. Ritu Garg, resigned effective close of business on October 31, 2026. The resignation is a senior management personnel change with no monetary impact stated.
Fortis Healthcare Board Meeting Date
Fortis Healthcare will hold a board meeting on 5 November 2026 to approve Q2 and half-year unaudited results and alter terms of ₹1,550 Crore listed NCDs. The filing is a prior intimation of the board meeting with agenda items only.
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Other results update announcements
All →GHCL Textiles Results Update
GHCL Textiles released Q2 and H1 FY27 press highlights, showing Q2 revenue up 31% and PAT up 249%. These are reported results highlights, not a new event.
Symbiotec Pharmalab Results Update
Symbiotec Pharmalab released its Q2 and H1 FY27 investor release, reporting consolidated Q2 revenue of ₹280 crore and PAT of ₹52 crore. The release also cites a ₹53 crore milestone revenue from a US licensing agreement.
Linc Results Update
Linc's Q2 FY27 total income rose 9.9% to ₹15,535 lakhs, but PAT fell 50.5% to ₹419 lakhs. Higher raw material costs and promotion spending squeezed margins.
Pearl Global Industries Results Update
Pearl Global's press release reports record H1 FY27 revenue of INR 3,330 crore. It also declares an interim dividend of INR 5.0 per share.
Tonbo Imaging India Results Update
Tonbo Imaging's press release reports half-year revenue up 183% year-on-year and a Q2 profit rebound. The results cover the quarter and half year ended September 30, 2026.
Shigan Quantum Technologies Results Update
Shigan Quantum reported H1 FY27 consolidated revenue up 18.1% to Rs 1,297.8 million. Consolidated PAT rose 51.8% year-on-year on the unaudited half-year results.